Cargando…

Terlipressin in septic shock: what do we know?

Detalles Bibliográficos
Autores principales:	Liu, Zi-Meng, Guan, Xiang-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212130/ https://www.ncbi.nlm.nih.gov/pubmed/32395303 http://dx.doi.org/10.21037/jtd.2020.02.40

Ejemplares similares

Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: Few Concerns
por: Khera, Daisy, et al.
Publicado: (2023)

Multinational monkeypox outbreak: what do we know and what should we do?
por: Memariani, Mojtaba, et al.
Publicado: (2022)

Terlipressin in the treatment of catecholamine resistant septic shock
por: Auzinger, GM, et al.
Publicado: (2002)

Author Reply: Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study
por: Sahoo, Pallavi, et al.
Publicado: (2023)

Coronavirus and ophthalmology: What do we know and way forward
por: Khanna, Rohit C
Publicado: (2020)

COVID-19 vaccines and pregnancy: What do we know?
por: Cottin, Judith, et al.
Publicado: (2021)

Vasopressin and terlipressin in adult vasodilatory shock
por: Polito, Angelo, et al.
Publicado: (2012)

Clinical review: Vasopressin and terlipressin in septic shock patients
por: Delmas, Anne, et al.
Publicado: (2005)

Rescue therapy in septic shock – is terlipressin the last frontier?
por: Leone, Marc, et al.
Publicado: (2006)

Effects of simultaneously infused terlipressin and dobutamine in septic shock
por: Morelli, A, et al.
Publicado: (2007)

Online Social Capital and Health What: We Know, What We Need to Know
por: Kwon, Youngbum
Publicado: (2021)

Mean Age of First Sex: Do They Know What We Mean?
por: de Irala, Jokin, et al.
Publicado: (2011)

Asymptomatic SARS-CoV-2 infections: What do we need to know?
por: Tan, Caixia, et al.
Publicado: (2020)

Hearing Loss in SARS-CoV-2: What Do We Know?
por: Saniasiaya, Jeyasakthy
Publicado: (2021)

Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’
por: Kow, Chia Siang, et al.
Publicado: (2023)

Continuous terlipressin versus vasopressin infusion in septic shock: the TERLIVAP study
por: Morelli, A, et al.
Publicado: (2008)

Vasopressin and terlipressin as first-line therapy in fulminant ovine septic shock
por: Rehberg, S, et al.
Publicado: (2008)

Using terlipressin in a pediatric patient with septic shock resistant to catecholamines
por: Erdogan, Seher, et al.
Publicado: (2017)

Ramipril poisoning rescued by naloxone and terlipressin
por: Samanta, Samanta, et al.
Publicado: (2014)

Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study
por: Wang, Jinlong, et al.
Publicado: (2022)

Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis
por: Huang, Po, et al.
Publicado: (2019)

Hyperbaric oxygen therapy for Crohn’s disease complications: What do we know? –Authors’ reply
por: Lansdorp, CA, et al.
Publicado: (2020)

The Effects of Economic Crisis on Health of the Serbian Population: What Do We Know So Far?
por: POPOVIC, Natasa, et al.
Publicado: (2019)

Pharmacological approach to iatrogenic bleeding during bronchoscopy: what do we know so far and where do we go from here?
por: Alfaiate, Ana, et al.
Publicado: (2023)

Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis
por: Huang, Lili, et al.
Publicado: (2020)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Rescue treatment with terlipressin in children with refractory septic shock: a clinical study
por: Rodríguez-Núñez, Antonio, et al.
Publicado: (2006)

Effects of vasopressin and terlipressin in ovine septic shock on mesenteric blood flow and survival
por: Rehberg, Sebastian, et al.
Publicado: (2007)

Terlipressin for septic shock patients: a meta-analysis of randomized controlled study
por: Zhu, Yibing, et al.
Publicado: (2019)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

What Do We Know about Early Management of Sepsis and Septic Shock in Polish Hospitals? A Questionnaire Study
por: Krzych, Łukasz J., et al.
Publicado: (2021)

Bronchoalveolar lavage fluid dilution in ICU patients: what we should know and what we should do
por: Yu, Yuetian, et al.
Publicado: (2019)

N-95 masks: how much do we know?
por: Bakshi, Satvinder Singh, et al.
Publicado: (2020)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Persistent pulmonary subsolid nodules with a solid component smaller than 6 mm: what do we know?
por: Qi, Linlin, et al.
Publicado: (2020)

Regarding Perspective Piece from July 2016 “What Do We Know About Chagas Disease in the United States?”
por: Nelson, Kenrad E., et al.
Publicado: (2017)

COVID‐19 infection as a possible cause of complete heart block: What do we know so far?
por: Abobaker, Anis
Publicado: (2022)

What artificial intelligence knows about 70 kDa heat shock proteins, and how we will face this ChatGPT era
por: Heck, Thiago Gomes
Publicado: (2023)

Coronavirus disease 2019 (COVID-19): What we need to know
por: Javanian, Mostafa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lsj5v45g59ssi94nunf85hor1j